CABP5 抗体 (AA 1-173)
Quick Overview for CABP5 抗体 (AA 1-173) (ABIN7146384)
抗原
See all CABP5 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-173
- 
                                            交叉反应
- 人, 小鼠
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Calcium-binding protein 5 protein (1-173AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:1000-1:5000,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - CABP5 (Calcium Binding Protein 5 (CABP5))
- 
                                            别名
- CABP5
- 
                                            背景
- 
                        Background: Inhibits calcium-dependent inactivation of L-type calcium channel and shifts voltage dependence of activation to more depolarized membrane potentials. Involved in the transmission of light signals. Aliases: CABP3 antibody, CaBP5 antibody, CABP5_HUMAN antibody, Calcium binding protein 3 antibody, Calcium-binding protein 5 antibody 
- 
                                            UniProt
- Q9NP86
 抗原
- 
                    
 
                                     
                                     
                                    